Halia Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
SALT LAKE CITY, Jan. 5, 2023 /PRNewswire/ -- Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by chronic inflammation, today announced that David J. Bearss, Ph.D., CEO of Halia Therapeutics, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, at 07:30 a.m. PST/10:30 a.m. EST.
- SALT LAKE CITY, Jan. 5, 2023 /PRNewswire/ -- Halia Therapeutics, a clinical stage biopharmaceutical company advancing innovative medicines to treat diseases driven by chronic inflammation, today announced that David J. Bearss, Ph.D., CEO of Halia Therapeutics, will present at the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, at 07:30 a.m. PST/10:30 a.m. EST.
- Where: Golden Gate (32nd floor), The Westin St. Francis, San Francisco